RARE DISEASE
Whipple disease
Whipple disease
Whipple disease
Synonyms: Intestinal lipodystrophy
Synonyms: Intestinal lipodystrophy
Synonyms: Intestinal lipodystrophy
Drug discovery
1
drug
With orphan designation
Overview
Whipple disease is a rare systemic infection caused by Tropheryma whipplei, a Gram-positive bacterium. It primarily affects the small intestine, causing malabsorption, with early symptoms including migratory arthritis and later progression to chronic diarrhea, weight loss, and abdominal pain. Extraintestinal manifestations (e.g., neurological, cardiac, ocular) may occur. Diagnosis relies on small-bowel biopsy demonstrating periodic acid-Schiff–positive macrophages and PCR confirmation. Treatment involves prolonged antibiotic regimens, typically starting with intravenous ceftriaxone followed by oral trimethoprim-sulfamethoxazole (TMP-SMX) for 1–2 years [1][3][5][13].
Population
Demographics: Predominantly affects middle-aged and elderly Caucasians (male-to-female ratio ~8:1); incidence peaks >65 years [2][5][14].
Risk Factors: Linked to occupational soil exposure (e.g., farming); genetic susceptibility (HLA alleles DRB113/DQB106) [4][10].
Prevalence: ~9.8 cases per 1 million in the U.S., higher in non-Hispanic whites [2][6].
Burden
Mortality: Untreated disease is fatal; CNS involvement increases mortality risk (33% in severe cases) [12][16].
Morbidity: Chronic malnutrition, neurological deficits (e.g., dementia), endocarditis, and arthritis [1][5][6].
Healthcare Utilization: Prolonged hospitalizations (mean 7.4 days) and high treatment costs [6][13].
Therapies
First-line: IV ceftriaxone (2–4 weeks) followed by oral TMP-SMX (1–2 years); alternatives include doxycycline + hydroxychloroquine [3][8][13].
Relapse Prevention: Lifelong doxycycline prophylaxis considered in recurrent cases [3][14].
Monitoring: Regular clinical/PCR surveillance due to relapse risk (up to 40%) [9][13].
Categories: rare gastroenterological diseases, rare genetic diseases, rare immunological diseases, rare infectious diseases, rare neurological diseases
Research Papers
313 drug discovery papers about Whipple disease, with 1 first-in-class emerging drug candidates forecasted to outperform the average preclinical success rate. Recent publications:
313 drug discovery papers about Whipple disease, with 1 first-in-class emerging drug candidates forecasted to outperform the average preclinical success rate. Recent publications:
categories:
Small molecules
2026-08-13 | Exploring treatment challenges in Whipple's disease: two case reports and review of the literature.
To review the literature concerning the antimicrobial treatment of Whipple's disease and to highlight consequences of diagnostic delay (including inappropriate use of immunosuppressants). This in the context of two illustrative case reports in which the standard treatment regimen of intravenous (IV) ceftriaxone for two weeks followed by oral trimethoprim-sulfamethoxazole (TMP-SMX) was either ineffective or poorly tolerated. A narrative review of the literature on antimicrobial treatment and the interplay of Whipple's disease with immunosuppressants was conducted alongside the clinical case descriptions. A review of the literature identified two principal treatment strategies in use: the standard IV ceftriaxone/TMP-SMX regimen and the doxycycline/hydroxychloroquine oral-only combination. Debate regarding optimal approach is ongoing, however several studies report on the failure or relapse of the standard IV regimen. Diagnostic delay and inappropriate use of immunosuppressants can lead to severe complications. In patients with Whipple's disease who fail or cannot tolerate the standard IV regimen, combination of doxycycline and hydroxychloroquine represents a viable and effective alternative in patients without cerebral involvement. Clinical awareness of this condition and its treatment options is essential for a timely diagnosis and appropriate management.
2026-07-30 | Oral Doxycycline Plus Low-dose Hydroxychloroquine Following Intravenous Ceftriaxone may be Effective for Whipple's Disease in Japan : A Case Report and Literature Review.
A 52-year-old woman presented with weight loss and fever of unknown origin that had persisted for one year. She presented with multiple lymphadenopathies, primarily within the abdominal cavity, but no joint symptoms were observed. A second upper endoscopy revealed diffuse white shaggy villi in the duodenum and the ileum. A definitive diagnosis of Whipple's disease was made based on electron microscopy and polymerase chain reaction (PCR) of the biopsy specimen. Treatment was initiated with doxycycline plus low-dose hydroxychloroquine oral therapy, followed by ceftriaxone intravenous infusion. Ten months after treatment, the patient responded successfully with no side effects.
2026-05-14 | Whipple's Disease Complicated by Severe Pulmonary Hypertension and Right Ventricular Failure.
Whipple's disease is a rare, chronic systemic infection caused by Tropheryma whipplei that commonly presents with gastrointestinal manifestations but may involve multiple extraintestinal organs. Cardiac involvement, particularly culture-negative endocarditis, is described; however, pulmonary complications such as pulmonary hypertension (PH) are uncommon. We report a case of Whipple's disease presenting with severe pre-capillary pulmonary hypertension and right ventricular (RV) failure with reversibility following antimicrobial therapy. A 62-year-old woman with seropositive rheumatoid arthritis on adalimumab, presented with one month of profuse watery diarrhoea, abdominal pain, dizziness and weakness. Imaging revealed diffuse mesenteric and para-aortic lymphadenopathy. Upper endoscopy demonstrated oedematous whitish granular villi in the duodenum, and biopsies showed periodic acid-Schiff-positive, acid-fast bacillus-negative foamy macrophages diagnostic of Whipple's disease. Transthoracic echocardiography revealed RV dilation and dysfunction with pulmonary hypertension, which was confirmed on right heart catheterisation as severe pre-capillary PH with elevated pulmonary vascular resistance and normal wedge pressure. The patient developed RV-predominant cardiogenic shock requiring inotropic and vasopressor support. Following initiation of intravenous ceftriaxone her haemodynamics improved rapidly, with normalisation of cardiac output and marked reduction in pulmonary pressures on repeat catheterisation. Gastrointestinal symptoms resolved, immunosuppressive therapy was discontinued, and she was discharged on prolonged antimicrobial therapy. This case underscores PH as a rare but potentially reversible manifestation of Whipple's disease. Recognition of this entity is critical, as PH-specific vasodilator therapy alone is often ineffective, whereas early targeted antimicrobial treatment can result in rapid and profound clinical and haemodynamic recovery, even in cases presenting with severe RV failure. Whipple's disease should be considered in the differential diagnosis of otherwise unexplained pre-capillary pulmonary hypertension, particularly when accompanied by chronic diarrhoea, arthralgia or systemic features.Unlike idiopathic pulmonary arterial hypertension, Whipple's disease-associated pulmonary hypertension is often driven by a reversible inflammatory process and may present with severe right ventricular failure and haemodynamic compromise.Recognition of this rare entity is critical, as pulmonary hypertension-specific vasodilator therapy alone is frequently insufficient, whereas timely initiation of targeted antimicrobial treatment can result in rapid and profound clinical and haemodynamic recovery.
2026-04-15 | Pulmonary infection caused by Tropheryma whipplei in a child before hematopoietic stem cell transplantation: a case report.
Tropheryma whipplei (TW) triggers Whipple's disease (WD), a rare, chronic multisystemic infection with heterogeneous clinical presentations that can be easily overlooked, particularly Whipple's pneumonia. The advent of metagenomic next-generation sequencing (mNGS) technology applied to bronchoalveolar lavage fluid (BALF) analysis has enabled the identification of an increasing number of patients with acute pneumonia due to TW. Most reports describe symptomatic middle-aged males with cough, while asymptomatic pediatric cases remain exceptionally rare. Without adequate antibiotic therapy, WD is invariably fatal, especially in patients undergoing hematopoietic stem cell transplantation (HSCT). There is no established consensus on the optimal treatment regimen or duration, particularly for pediatric patients. An 8-year-old boy with primary immunodeficiency due to a genetic mutation presented without respiratory symptoms. Yet, high-resolution computed tomography (HRCT) revealed nodular lesions. Initially misdiagnosed as a fungal infection, subsequent mNGS analysis of BALF identified TW as the sole pathogen, leading to a diagnosis of TW-associated pneumonia. Following a combined anti-infective therapy regimen, the patient successfully underwent the myeloablative conditioning (MAC) regimen. Neutrophil and platelet engraftment occurred promptly, with no severe transplant-related complications. This retrospective analysis describes a clinical scenario involving a pediatric patient who exhibited no respiratory symptoms prior to transplantation but showed characteristic nodular lesions on imaging studies, ultimately confirming acute pneumonia caused by TW. Under a combination anti-infection regimen consisting of intravenous ceftriaxone, oral doxycycline, and oral hydroxychloroquine, the child tolerated the MAC regimen well. Neutrophil and platelet engraftment proceeded without delay, and follow-up imaging confirmed complete resolution of the pulmonary lesions.
2026-04-14 | Whipple's disease with multiple serous effusions as the clinical manifestation: a case report and literature review.
Whipple's disease, caused by Tropheryma whipplei, is a rare multisystem infectious disorder with diverse clinical manifestations. Typical symptoms include arthralgia, nausea, vomiting, diarrhoea, and weight loss, while nonspecific features such as fever, anaemia, and lymphadenopathy may also occur. Presentations with multiple serous effusions are exceedingly rare. Diagnosis remains particularly challenging in resource-limited regions because of nonspecific symptoms and limited access to advanced diagnostic techniques. A 34-year-old male presented with fever, vomiting, diarrhoea, mild dry cough, and anorexia. Whole-body computed tomography revealed systemic inflammatory changes that mimicked vasculitis, including multiple serous effusions (pleural, peritoneal, pericardial, and pelvic) and omental thickening. Initial anti-infective therapy failed. Serological tests, pleural fluid analysis, and thoracoscopic pleural biopsy excluded systemic vasculitis and pleural malignancy. Given the diagnostic uncertainty, subsequently 18F-fluorodeoxyglucose positron emission tomography demonstrated diffuse peritoneal thickening accompanied by hypermetabolism, which prompted a biopsy. Definitive diagnosis was achieved via laparoscopic omental biopsy with histopathology, periodic acid-Schiff staining, and polymerase chain reaction. Despite receiving targeted antibiotic therapy for T. whipplei, the patient showed suboptimal clinical improvement. We speculated that the recurrence of the patient's condition was more likely attributable to immune reconstitution inflammatory syndrome. Combination therapy with doxycycline, hydroxychloroquine, and short-term glucocorticoids induced sustained remission. After more than 2 years of targeted anti-T. whipplei therapy, the patient demonstrated a favourable recovery. Multiple serous effusions are uncommon clinical manifestations of Whipple's disease. Early identification of T. whipplei infection and timely targeted therapy are critical for improving patient prognosis.
2026-08-13 | Exploring treatment challenges in Whipple's disease: two case reports and review of the literature.
To review the literature concerning the antimicrobial treatment of Whipple's disease and to highlight consequences of diagnostic delay (including inappropriate use of immunosuppressants). This in the context of two illustrative case reports in which the standard treatment regimen of intravenous (IV) ceftriaxone for two weeks followed by oral trimethoprim-sulfamethoxazole (TMP-SMX) was either ineffective or poorly tolerated. A narrative review of the literature on antimicrobial treatment and the interplay of Whipple's disease with immunosuppressants was conducted alongside the clinical case descriptions. A review of the literature identified two principal treatment strategies in use: the standard IV ceftriaxone/TMP-SMX regimen and the doxycycline/hydroxychloroquine oral-only combination. Debate regarding optimal approach is ongoing, however several studies report on the failure or relapse of the standard IV regimen. Diagnostic delay and inappropriate use of immunosuppressants can lead to severe complications. In patients with Whipple's disease who fail or cannot tolerate the standard IV regimen, combination of doxycycline and hydroxychloroquine represents a viable and effective alternative in patients without cerebral involvement. Clinical awareness of this condition and its treatment options is essential for a timely diagnosis and appropriate management.
2026-07-30 | Oral Doxycycline Plus Low-dose Hydroxychloroquine Following Intravenous Ceftriaxone may be Effective for Whipple's Disease in Japan : A Case Report and Literature Review.
A 52-year-old woman presented with weight loss and fever of unknown origin that had persisted for one year. She presented with multiple lymphadenopathies, primarily within the abdominal cavity, but no joint symptoms were observed. A second upper endoscopy revealed diffuse white shaggy villi in the duodenum and the ileum. A definitive diagnosis of Whipple's disease was made based on electron microscopy and polymerase chain reaction (PCR) of the biopsy specimen. Treatment was initiated with doxycycline plus low-dose hydroxychloroquine oral therapy, followed by ceftriaxone intravenous infusion. Ten months after treatment, the patient responded successfully with no side effects.
2026-05-14 | Whipple's Disease Complicated by Severe Pulmonary Hypertension and Right Ventricular Failure.
Whipple's disease is a rare, chronic systemic infection caused by Tropheryma whipplei that commonly presents with gastrointestinal manifestations but may involve multiple extraintestinal organs. Cardiac involvement, particularly culture-negative endocarditis, is described; however, pulmonary complications such as pulmonary hypertension (PH) are uncommon. We report a case of Whipple's disease presenting with severe pre-capillary pulmonary hypertension and right ventricular (RV) failure with reversibility following antimicrobial therapy. A 62-year-old woman with seropositive rheumatoid arthritis on adalimumab, presented with one month of profuse watery diarrhoea, abdominal pain, dizziness and weakness. Imaging revealed diffuse mesenteric and para-aortic lymphadenopathy. Upper endoscopy demonstrated oedematous whitish granular villi in the duodenum, and biopsies showed periodic acid-Schiff-positive, acid-fast bacillus-negative foamy macrophages diagnostic of Whipple's disease. Transthoracic echocardiography revealed RV dilation and dysfunction with pulmonary hypertension, which was confirmed on right heart catheterisation as severe pre-capillary PH with elevated pulmonary vascular resistance and normal wedge pressure. The patient developed RV-predominant cardiogenic shock requiring inotropic and vasopressor support. Following initiation of intravenous ceftriaxone her haemodynamics improved rapidly, with normalisation of cardiac output and marked reduction in pulmonary pressures on repeat catheterisation. Gastrointestinal symptoms resolved, immunosuppressive therapy was discontinued, and she was discharged on prolonged antimicrobial therapy. This case underscores PH as a rare but potentially reversible manifestation of Whipple's disease. Recognition of this entity is critical, as PH-specific vasodilator therapy alone is often ineffective, whereas early targeted antimicrobial treatment can result in rapid and profound clinical and haemodynamic recovery, even in cases presenting with severe RV failure. Whipple's disease should be considered in the differential diagnosis of otherwise unexplained pre-capillary pulmonary hypertension, particularly when accompanied by chronic diarrhoea, arthralgia or systemic features.Unlike idiopathic pulmonary arterial hypertension, Whipple's disease-associated pulmonary hypertension is often driven by a reversible inflammatory process and may present with severe right ventricular failure and haemodynamic compromise.Recognition of this rare entity is critical, as pulmonary hypertension-specific vasodilator therapy alone is frequently insufficient, whereas timely initiation of targeted antimicrobial treatment can result in rapid and profound clinical and haemodynamic recovery.
2026-04-15 | Pulmonary infection caused by Tropheryma whipplei in a child before hematopoietic stem cell transplantation: a case report.
Tropheryma whipplei (TW) triggers Whipple's disease (WD), a rare, chronic multisystemic infection with heterogeneous clinical presentations that can be easily overlooked, particularly Whipple's pneumonia. The advent of metagenomic next-generation sequencing (mNGS) technology applied to bronchoalveolar lavage fluid (BALF) analysis has enabled the identification of an increasing number of patients with acute pneumonia due to TW. Most reports describe symptomatic middle-aged males with cough, while asymptomatic pediatric cases remain exceptionally rare. Without adequate antibiotic therapy, WD is invariably fatal, especially in patients undergoing hematopoietic stem cell transplantation (HSCT). There is no established consensus on the optimal treatment regimen or duration, particularly for pediatric patients. An 8-year-old boy with primary immunodeficiency due to a genetic mutation presented without respiratory symptoms. Yet, high-resolution computed tomography (HRCT) revealed nodular lesions. Initially misdiagnosed as a fungal infection, subsequent mNGS analysis of BALF identified TW as the sole pathogen, leading to a diagnosis of TW-associated pneumonia. Following a combined anti-infective therapy regimen, the patient successfully underwent the myeloablative conditioning (MAC) regimen. Neutrophil and platelet engraftment occurred promptly, with no severe transplant-related complications. This retrospective analysis describes a clinical scenario involving a pediatric patient who exhibited no respiratory symptoms prior to transplantation but showed characteristic nodular lesions on imaging studies, ultimately confirming acute pneumonia caused by TW. Under a combination anti-infection regimen consisting of intravenous ceftriaxone, oral doxycycline, and oral hydroxychloroquine, the child tolerated the MAC regimen well. Neutrophil and platelet engraftment proceeded without delay, and follow-up imaging confirmed complete resolution of the pulmonary lesions.
2026-04-14 | Whipple's disease with multiple serous effusions as the clinical manifestation: a case report and literature review.
Whipple's disease, caused by Tropheryma whipplei, is a rare multisystem infectious disorder with diverse clinical manifestations. Typical symptoms include arthralgia, nausea, vomiting, diarrhoea, and weight loss, while nonspecific features such as fever, anaemia, and lymphadenopathy may also occur. Presentations with multiple serous effusions are exceedingly rare. Diagnosis remains particularly challenging in resource-limited regions because of nonspecific symptoms and limited access to advanced diagnostic techniques. A 34-year-old male presented with fever, vomiting, diarrhoea, mild dry cough, and anorexia. Whole-body computed tomography revealed systemic inflammatory changes that mimicked vasculitis, including multiple serous effusions (pleural, peritoneal, pericardial, and pelvic) and omental thickening. Initial anti-infective therapy failed. Serological tests, pleural fluid analysis, and thoracoscopic pleural biopsy excluded systemic vasculitis and pleural malignancy. Given the diagnostic uncertainty, subsequently 18F-fluorodeoxyglucose positron emission tomography demonstrated diffuse peritoneal thickening accompanied by hypermetabolism, which prompted a biopsy. Definitive diagnosis was achieved via laparoscopic omental biopsy with histopathology, periodic acid-Schiff staining, and polymerase chain reaction. Despite receiving targeted antibiotic therapy for T. whipplei, the patient showed suboptimal clinical improvement. We speculated that the recurrence of the patient's condition was more likely attributable to immune reconstitution inflammatory syndrome. Combination therapy with doxycycline, hydroxychloroquine, and short-term glucocorticoids induced sustained remission. After more than 2 years of targeted anti-T. whipplei therapy, the patient demonstrated a favourable recovery. Multiple serous effusions are uncommon clinical manifestations of Whipple's disease. Early identification of T. whipplei infection and timely targeted therapy are critical for improving patient prognosis.
Access all drug discovery papers and probability of success in trials forecasts:
Access all drug discovery papers and probability of success in trials forecasts:
Drug Discovery Landscape
1 orphan drug designation for Whipple disease.
1 orphan drug designation for Whipple disease.
Drug | Therapy type | Regulator | Orphan designation | Approval | Sponsor |
|---|---|---|---|---|---|
emodepside | — | FDA | 2025-04-17 | — | Bayer HealthCare Pharmaceuticals Inc. |
Let's accelerate rare disease drug discovery
Let's accelerate drug discovery
Get access to Explority AI’s forecasts to outperform average preclinical success rates. Whether you’re expanding your R&D pipeline, evaluating a partnership, or simply have a question — we’d love to hear from you.